EtoposideInjectionsAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsTopoisomerase II InhibitorsInjections, IntravenousIfosfamideCisplatinInjections, IntramuscularCarcinoma, Small CellDNA Topoisomerases, Type IIPodophyllotoxinDoxorubicinVincristineInjections, IntralesionalCyclophosphamideInjections, SubcutaneousInjections, Intra-ArticularDrug Administration ScheduleCarboplatinAmsacrineInjections, IntraperitonealBleomycinLung NeoplasmsCombined Modality TherapyAntineoplastic AgentsCytarabineDose-Response Relationship, DrugGerminomaTreatment OutcomeInjections, IntradermalInjections, EpiduralInjections, IntraventricularTeniposideTime FactorsApoptosisLeukopeniaInjections, Intra-ArterialTransplantation, AutologousNucleic Acid Synthesis InhibitorsTopoisomerase InhibitorsAdministration, OralIntravitreal InjectionsInfusions, IntravenousInjections, SpinalTesticular NeoplasmsDrug Resistance, NeoplasmRemission InductionMitoxantroneInjections, JetTumor Cells, CulturedNeoplasms, Germ Cell and EmbryonalInjections, IntraocularDNA DamageDrug EvaluationHodgkin DiseaseCarmustineCamptothecinHematologic DiseasesLymphoma, Non-HodgkinSalvage TherapySurvival AnalysisTopotecanTopoisomerase I InhibitorsDisease-Free SurvivalRats, Sprague-DawleySurvival RateOrganophosphorus CompoundsThrombocytopeniaNeutropeniaDrug ResistanceRazoxaneCell SurvivalPrednisoneDrug Resistance, MultipleP-GlycoproteinFlow Injection AnalysisProcarbazineMicroinjectionsPaclitaxelCell Line, TumorVinblastineMelphalanDisease Models, AnimalGranulocyte Colony-Stimulating FactorDrug SynergismMethotrexateSubstance Abuse, IntravenousAlopeciaRetroperitoneal NeoplasmsDaunorubicinSperm Injections, IntracytoplasmicBone Marrow DiseasesHematopoietic Stem Cell TransplantationMice, Inbred C57BLNeoplasmsDrug Screening Assays, AntitumorHalf-LifeAntibiotics, AntineoplasticHL-60 Cells